Indicated for: asthma; chronic obstructive pulmonary disease
Route of administration: oral
Substance: salbutamol (beta-2 adrenergic agonist)
ATC: R03CC02 (Respiratory system | Adrenergics for systemic use | Selective beta-2-adrenoreceptor agonists)
Salbutamol is a fast-acting beta-2 adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). It works by relaxing the smooth muscles of the airways, facilitating breathing and relieving symptoms such as shortness of breath, wheezing, and chest tightness.
Salbutamol is typically administered via inhalation using a pressurized inhaler or nebulizer and is indicated for the rapid relief of acute symptoms or the prevention of exercise-induced bronchospasm. It is considered a rescue medication due to its quick onset of action.
Common side effects include tremors, palpitations, headache, and throat irritation. In rare cases, severe adverse reactions such as hypokalemia, tachycardia, or paradoxical bronchospasm may occur. It is important for patients to adhere to the prescribed dosage to avoid overdose and adverse effects.
Salbutamol is an essential therapeutic option for patients with respiratory conditions, providing rapid and effective relief of acute symptoms and improving their quality of life.
Price
Copayment
Patient
13.55 RON
12.20 RON
1.36 RON